Table 2

Comparison in outcomes according to number of passes (≤3 vs.>3) among patients with successful recanalization (mTICI 2b/3) after mechanical thrombectomy

OutcomesNumber of passesUnadjusted analysesPre-specified adjusted analyses*
≤3 (n=212)>3 (n=69)OR (95% CI)P valuesOR (95% CI)P values
Favorable outcome118/206 (57.3)25/64 (39.1)0.48 (0.26 to 0.85)0.0120.64 (0.29 to 1.43)0.27
90-day mRS†2 (1 to 4)3 (1 to 5)0.53 (0.32 to 0.87)0.0110.73 (0.41 to 1.29)0.27
Any ICH88/207 (42.5)43/69 (62.3)2.24 (1.27 to 3.93)0.0051.75 (0.91 to 3.36)0.096
Parenchymal hematoma21/207 (10.1)21/69 (30.4)3.88 (1.95 to 7.70)0.0013.62 (1.55 to 8.44)0.003
Subarachnoid hemorrhage13/207 (6.3)6/69 (8.7)1.42 (0.51 to 3.92)0.40NA
90-day mortality30/206 (14.6)12/64 (18.8)1.36 (0.64 to 2.84)0.420.74 (0.27 to 2.05)0.57
  • Values expressed as no./total no. (%) or median (IQR)

  • *calculated using a mixed (binary or ordinal) logistic regression model including center as random effect, first-line thrombectomy device, age, admission NIHSS, ASPECTS, pre-stroke mRS ≥1, intravenous rt-PA, onset to recanalization time and mTICI grades (2b vs 2 c/3).

  • †shift-analysis (OR per 1 point-improvement in mRS)

  • ASPECTS, Alberta stroke program early CT score; ICH, intracerebral hemorrhage; mRS, modified Rankin scale; mTICI, modified treatment in cerebral infarction score; NA, not applicable; NIHSS, National Institute of Health Stroke Scale; OR, OR ratio; rt-PA, recombinant tissue plasminogen activator.